METTL21A通过甲基化和稳定BAG3促进肝细胞癌的进展
Ping Zhan1, Yizhe Cheng1, Yingcan Wu1
1Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
NPJ precision oncology
|July 10, 2025
概括
甲基转移酶21A (METTL21A) 通过抑制蛋白质降解来驱动肝细胞癌 (HCC) 的生长. 用sophoricoside向METTL21A为HCC提供了一个潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白甲基转移酶在细胞过程中至关重要.
- 非基因组甲基转移酶,如METTL21A在肝细胞癌 (HCC) 中的作用尚不清楚.
- 了解METTL21A在HCC中的功能对于开发新疗法至关重要.
研究的目的:
- 研究甲基转移酶21A (METTL21A) 在肝细胞癌 (HCC) 进展中的作用.
- 阐明METTL21A促进HCC的分子机制.
- 探索向METTL21A在HCC中的治疗潜力.
主要方法:
- 对HCC组织中METTL21A表达的分析.
- 在METTL21A.的体外和体内功能研究.
- 研究METTL21A与BAG3和TRIM21.21的相互作用.
- 评估sophoricoside作为一个METTL21A抑制剂.
主要成果:
- 在HCC中,METTL21A受到上调,并与预后不佳有关.
- METTL21A促进了HCC的生长和转移.
- METTL21A通过TRIM21.21阻止BAG3降解,通过TRIM21.21阻止其无处不在的降解.
- 索福里科赛德抑制METTL21A,并显示出抗HCC活性.
结论:
- METTL21A是HCC中的一种瘤基因,促进瘤的进展.
- METTL21A的机制包括抑制BAG3降解.
- METTL21A是HCC的潜在治疗点.
- 索福里科赛德作为抗HCC药物表现有前途.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K


